FBR Capital Initiates Biocryst Pharmaceuticals With Outperform - BioCryst Pharma (NASDAQ:BCRX)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Analysts at FBR Capital initiated coverage on

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Biocryst Pharmaceuticals, Inc.

(NASDAQ: BCRX) with a Outperform rating.The target price for Biocryst Pharmaceuticals is set to $18.Biocryst Pharmaceuticals shares have gained 11.85 percent over the past 52 weeks, while the S&P 500 index has surged 11.75 percent in the same period.Biocryst Pharmaceuticals' shares rose 6.90 percent to $11.00 in pre-market trading.